PDK4 and coronary artery disorder: These findings highlight the therapeutic potential of targeting PDK4 to address the multifaceted challenges associated with ischemic heart disease.[75] It also promotes vascular calcification by disrupting autophagy and shifting vascular smooth muscle cells (VSMCs) toward glycolysis, which reduces mitochondrial function and leads to calcium buildup.